
Sign up to save your podcasts
Or


While the rapid evolution of I-O continues to bring unprecedented change to the way cancer is treated, there are significant gaps impacting the laboratory team regarding the examination of resection specimens following neoadjuvant immunotherapy and staying abreast of advances in I-O biomarker testing.
This episode discusses advances in I-O biomarker testing, advantages and limitations of some key I-O biomarkers, and practical ways that pathologists and laboratory professionals can improve their I-O biomarker testing workflows to optimize patient care.
Topics discussed include:
By American Society for Clinical Pathology4.6
4747 ratings
While the rapid evolution of I-O continues to bring unprecedented change to the way cancer is treated, there are significant gaps impacting the laboratory team regarding the examination of resection specimens following neoadjuvant immunotherapy and staying abreast of advances in I-O biomarker testing.
This episode discusses advances in I-O biomarker testing, advantages and limitations of some key I-O biomarkers, and practical ways that pathologists and laboratory professionals can improve their I-O biomarker testing workflows to optimize patient care.
Topics discussed include:

38,789 Listeners

25,888 Listeners

11,499 Listeners

2,059 Listeners

497 Listeners

6,355 Listeners

87,159 Listeners

16,901 Listeners

30 Listeners

8,584 Listeners

6,357 Listeners

2,278 Listeners

7,772 Listeners

85 Listeners

5,719 Listeners